Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Free Cash Flow Generation Index
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. free cash flow generation index. Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Free Cash Flow Generation Index of -6.61x as of December 2023. Free cash flow of CN¥-598.15 Million represents -7% of operating cash flow (CN¥90.45 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2023)
Free cash flow generation index of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. from 2019 to 2023. Historical FCF Generation Index trend for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. across 5 annual periods. See how financially flexible is Hangzhou Bio-Sincerity Pharma-Tech Co.Lt to measure the company's free cash flow as a share of total liabilities.
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Free Cash Flow Generation Index by Year (2019–2023)
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. free cash flow generation index by year from 2019 to 2023. Year-by-year Free Cash Flow Generation Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. For the full cash flow conversion analysis, see 301096 operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -6.61x | CN¥-598.15 Million | CN¥90.45 Million | CN¥688.60 Million | ▼ -416.4% |
| 2022 | -1.28x | CN¥-332.16 Million | CN¥259.41 Million | CN¥591.58 Million | ▼ -80.7% |
| 2021 | -0.71x | CN¥-103.02 Million | CN¥145.42 Million | CN¥248.45 Million | ▲ +80.8% |
| 2020 | -3.69x | CN¥-200.76 Million | CN¥54.36 Million | CN¥255.12 Million | ▼ -643.8% |
| 2019 | -0.50x | CN¥-35.48 Million | CN¥71.47 Million | CN¥106.95 Million | — |